Category Health & pharma

CVS Health beats expectations as turnaround strategy gains traction
CVS Health delivered a stronger-than-expected fourth quarter, beating Wall Street estimates on both earnings and revenue as the company presses ahe...
Feb, 10, 2026
3 min read
by Invezz

What analysts think of Novo, Him & Hers after obesity pill withdrawal
Novo Nordisk’s Denmark-listed shares climbed more than 7%, while the stock gained close to 6% in US premarket trading after telehealth company Hims...
Feb, 09, 2026
4 min read
by Invezz

Why a $49 weight-loss pill is rattling Novo Nordisk and Eli Lilly
Novo Nordisk and Eli Lilly are facing an uncomfortable new price point this week after a $49 weight-loss pill jolted the GLP-1 market. By launching...
Feb, 05, 2026
2 min read
by Invezz

